
General Internal Medicine

The ATLAS Trial: Angiotensin converting enzyme inhibitor dosing in chronic heart failure
This is a Module from the Course

The BHAT: Propranolol after acute myocardial infarction
This is a Module from the Course

The CARE Trial: Pravastatin reduces risk of coronary events
This is a Module from the Course

The CAST Trial: Anti-arrhythmic agents increase risk of death in patients after myocardial infarction
This is a Module from the Course

The CHADS2 score Trial: Stroke risk in atrial fibrillation
This is a Module from the Course

The CONSENSUS Trial: Enalapril reduces mortality in severe heart failure
This is a Module from the Course

The DASH trial: Diet change significantly reduces blood pressure
This is a Module from the Course

The DIG Trial: Digoxin reduces hospitalization in patients with systolic heart failure
This is a Module from the Course

The ENHANCE trial: Simvastatin and ezetimibe in familial hypercholesterolemia
This is a Module from the Course

The FAME 3 Trial: Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery
This is a Module from the Course

The HMPS I trial: Adverse events in patients and negligence
This is a Module from the Course

The HOPE Trial: Ramipril reduces cardiovascular events in high-risk patients with normal ejection fractions
This is a Module from the Course

The HOT trial: Diastolic blood pressure targets in hypertension
This is a Module from the Course

The JUPITER: Rosuvastatin reduces the risk of major cardiovascular events in healthy patients
This is a Module from the Course

The LRC-CPPT 1: Cholestyramine and coronary heart disease
This is a Module from the Course

The MERIT-HF Trial: Metoprolol reduces mortality in patients with symptomatic heart failure
This is a Module from the Course

The Overactive Thyroid and Thyroid Lumps in Children
This is a Module from the Course

The RALES Trial: Spironolactone reduces mortality in heart failure patients
This is a Module from the Course

The RAVE trial: Rituximab induces remission in ANCA-associated vasculitis
This is a Module from the Course

The REMATCH Trial: Left ventricular assist devices reduce mortality in heart failure
This is a Module from the Course